Qiagen net income 2012-2022

Published by
Matej Mikulic,
Mar 16, 2023
This statistic shows the development of the net income of Dutch biotech company Qiagen from 2012 to 2022. In 2022, net income of this company stood at some 423 million U.S. dollars. Qiagen N.V. is headquartered in the Netherlands and in Germany, and is operating in many countries around the world. The company is specialized on sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.

Net income of biotech company Qiagen from 2012 to 2022 (in million U.S. dollars)

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2023

Region

Worldwide

Survey time period

2012 to 2022

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

6

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology in EuropeBiotech drugsPharmaceutical industry in the U.S.Top pharmaceutical drugsBiotechnology industry in Germany
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu